genes and their cloning, expression, sequencing and chromosomallocations, the regulation of the genes and enzymesand even someintelligent guesses about their evolutionary relationships. The key breakthrough that led to rapid progress in these areas was the subcellular work done by Edward P. Abrahamand his Oxford colleagues in the early 1970s. With his advice and encouragement, mylaboratory was able to prepare reliably active soluble cell-free preparations which were instrumental in elucidation of the biosynthetic pathways in fungi (and also in bacteria) by laboratories throughout the world. valine into the hydrophobic penicillin G!'2). Furthermore, the sidechain was found to be formed from phenylacetate3). Using washed and starved resting cells, I was able to show that cystine stimulated and S-ethyl-DL-cysteine and amethyl-DL-valine inhibited penicillin G production by Penicillium chrysogenum and that these inhibitions could be reversed by L-cystine and DL-valine respectively4F urthermore, D-valine was shown to be an inhibitor of penicillin synthesis while L-valine stimulated, suggesting that the precursor of the D-valine moiety was L-valine.
I next tested the effect of all the other protein amino acids on synthesis by starved resting cells and made the unexpected observation that L-lysine was inhibitory5).
The results appeared to explain previous results by Bonner6) who found lysine auxotrophs to be poor penicillin producers; the added lysine (required for growth) apparently inhibited the process. The significance of the lysine effect was unknown. Also unknown was the mechanism by which cysteine and valine condensed in forming the penicillin nucleus or the stage at which phenylacetate was incorporated as sidechain. Of interest here was the discovery by Kato7) of an unknowncompound (thought to be the "penicillin nucleus") only in fermentations conducted in the absence of the sidechain precursor, phenylacetate. In 1955, I was able to confirm the production of "Kato's compound" cited in Demain8) which was later identified as 6-aminopenicillanic acid (6APA)9). Little did we know at that time that the lysine effect was related to sidechain attachment. However, we soon found out that lysine inhibition of penicillin synthesis by resting cells could be reversed by a-aminoadipate and that a-aminoadipate also stimulated penicillin formation in the absence of added lysine10). We concluded that the relative concentration of lysine and a-aminoadipate is crucial to penicillin formation, that a-aminoadipate has a role in penicillin synthesis, and that lysine interferes with that role. The role became clearer when the report of Arnsteinh) was considered. These workers had found that <5-(a-aminoadipyl)cysteinylvaline (ACV) was formed intracellularly during penicillin G biosynthesis. They speculated that ACVis cyclized to a penicillin containing an a-aminoadipate sidechain which would then exchange this sidechain with phenylacetate to produce penicillin G. represented the first naturally-.occuring /3-lactam antibiotic without a 6APA nucleus, possessing instead the 7-aminocephalosporanic acid nucleus24). The culture also produced a steroidal antibiotic called "cephalosporin P"25).
It was of interest that both penicillin N and cephalosporin C from Cephalosporium contained a D-a-aminoadipate sidechain whereas the isopenicillin N from P. chrysogenum contained an L-a-aminoadipate sidechain.
With regard to the biosynthetic pathway to cephalosporin C in Cephalosporium acremonium(knownat various times as Cephalosporum sp., Acremonium strictum and, most recently, Acremonium chrysogenum), Abraham's group showed that the acetoxy group is derived from acetate2-6* and cysteine is incorporated intact into the./J-lactam ring27). The sites of incorporation were the thiazolidine ring for valine and the sidechain for aminoadipate26'27*. It was clear in the early 1970s that studies with intact cells had revealed the precursors of /3-lactams but firm knowledge of the pathway and the enzymes involved was not at hand. What was needed was a new breakthrough involving cell-free systems and this was again provided by Edward Abraham.At a symposiumon antibiotics taking place in St. Marguerite in the Canadian Laurentians in early 1971, Abrahamannounced that he and Bronwell Loder had converted labelled phenylacetate plus coenzyme A and either 6APA or isopenicillin N to labelled penicillin using a broken cell system from P. chrysogenum2^. He concluded that the reactions occurred in the following order: isopenicillin N -»penicillin G<-> 6APA. Also in that year, they29) had isolated three peptides from mycelium of C acremonium, one of which was 5-(L-a-aminoadipyl)-Lcysteinyl-D-valine (LLD-ACV). They postulated that The ability to produce tripeptide but not antibiotic from dipeptide plus valine using broken cells of C. acremonium31'32^suggested to us that the enzymatic system responsible for the biosynthesis of /3-lactam antibiotics was part of an unstable complex, and that the structure of this complex was destroyed by drastic treatments. In an earlier paper, Abraham33) had suggested that the conversion of cells into protoplasts followed by gentle lysis might preserve the integrity of the biosynthetic system. In preliminary work, Duncan and Newton34) observed the incorporation of labelled L-valine into penicillin N by a sonicated protoplast preparation from C. acremonium.
Furthermore, lyzed protoplasts could convert labelled valine in the presence of <5-(L-a-aminoadipyl)-L-cysteine, ATPand an energy-generating system into a penicillin; it also converted labelled LLD-ACVinto penicillin N32). In a letter to me dated December 17, 1973, Abraham stated that his lyzed protoplast-derived cell-free systems "may not be generally applicable, however, because we were only successful with one out of three other strains of P.
chrysogenum". He further wrote that the yields of penicillin N produced from labelled valine by lyzed protoplasts of C. time experiments (up to 5 hours)36). The system was insensitive to Millipore filtration or cycloheximide and the product was a cephalosporin. The reaction was markedly stimulated by the addition of penicillin N but not by penicillin G or 6APA. This strongly indicated that penicillin N was being converted to a cephalosporin, the first time that biological ring expansion of a penicillin had been observed. Up until this time, penicillin N and cephalosporin C had been generally considered to be end products of a branched pathway in C. acremonium. Here it was demonstrated that penicillin N was a precursor of a cephalosporin. Wewent on to show37) that the product made from penicillin N was deacetoxycephalosporin C (DOAC).
Mutants blocked early in biosynthesis, which made no antibiotic in fermentations, were able to carry out cell-free ring expansion. Later blocked mutants, which produced penicillin N but not cephalosporin C in fermentation, were incapable of cell-free ring expansion and were presumably blocked in the deacetoxycephalosporin C synthase reaction. Wegave the trival name"expandase" to this enzyme.
At this point, we were concerned that in both our laboratory35) and that of Abraham32'34'38), lyzed C.
acremoniumprotoplasts converted labelled valine into what was thought to be penicillin N but not into a cephalosporin. If it truly was penicillin N, why was it not converted into DOAC? Weapproached this problem by postulating that the product was not penicillin N but isopenicillin N, which had previously been detected only in P. chrysogenum. Toshio Konomi, a visiting scientist from Japan in my laboratory,
added LLD-ACV to our C. acremonium cell-free extracts and examined the antibacterial spectrum of the penicillinase-labile product. He had previously determined that penicillin N inhibited the growth of Salmonella typhimurium ATCC1331 1 and Pseudomonas aeruginosa Pss but not that of Staphylococcus aureus ATCC25923 or Sarcina lutea ATTC9341, whereas isopenicillin N had the opposite pattern. Wefound the reaction product to have the antibacterial spectrum of isopenicillin N. At this time, we were preparing to present this exciting result at an our bioassay plates to demonstrate our discovery. Fig. 1 shows the distinguished international group gathered for the symposium. Professor Abrahamwas given the initial spot on the program and I was to follow. I was shocked to hear him announce that O'Sullivan and he had made the same discovery by chemical detection of isopenicillin N. In discussing the findings of both laboratories with Abraham after the meeting, he generously proposed that they delay publication of their paper until we prepared our manuscript. As a result, both papers39'40) appeared back-to-back in the same issue of the Biochemical Journal.
Cell-free extracts were also crucial in defining the role of 6APA, or lack of one, in penicillin G biosynthesis. Although 6APAaccumulated in P. chrysogenum broths to which no sidechain precursor had been added, we doubted that free 6APA had a role in de novo biosynthesis of penicillin G41). We felt that it was merely a shunt metabolite derived by deacylation of isopenicillin N in the absence of phenylacetate addition. Cell-free studies had: indicated that the terminal reaction of penicillin G biosynthesis was an exchange of the L-a-aminoadipate sidechain of isopenicillin N for phenylacetate from phenylacetylcoenzyme A. Such acyltransferase activity had been found in crude extracts and phenylacetyl-CoA had been shown to arise from phenylacetate and coenzyme A by the action ofa sidechain activating enzyme. The appearance of the enzyme preceded rapid penicillin G formation and declined at the same time as the penicillin G production rate in fermentations. In the absence of phenylacetyl-CoA, isopenicillin N was hydrolyzed to 6APA by penicillin acyltransferase42). This free 6APAmay be converted later to penicillin G if phenylacetyl-CoA becomes available. This reasoning implicated isopenicillin N as the true immediate precursor of penicillin G and 6APAacylation as a salvage pathway. The observation in the Abraham laboratory43) that extracts could convert isopenicillin N, but not penicillin N, to penicillin G was consistent with the above concept.
Rapid progress was made following the cell-free discoveries described above. The ring expansion of penicillin N to DOACwas improved markedly by the work of Hook44), our own later studies45'46) and those of Felix47), which showed the importance of ascorbate, a-ketoglutarate VOL.53 NO. 10 THE JOURNAL OF ANTIBIOTICS and iron for this dioxygenase reaction. The preceeding reaction, the cyclization of LLD-ACVto isopenicillin N (to which we gave the trivial name "cyclase", otherwise known as isopenicillin N synthase or IPNS), was found to be stimulated by ferrous ions48). For preparing cell-free extracts containing active cyclase and expandase, the laborious protoplast formation and lysis procedure was replaced by simple sonic oscillation. The question still remained as to why the cell-free C. acremonium preparations converted LLD-ACV or valine into isopenicillin N but not into penicillin N and cephalosporins.
The answer was provided by Konomi40) who showed that fresh cell-free extracts could convert LLD-ACV to a cephalosporin but frozen and thawed extracts could not, the reaction sequence stopping at isopenicillin N. Thus an extremely labile epimerase [called "racemase" by Konomi40)] existed which could convert isopenicillin N to penicillin N, thus changing the configuration of the a-aminoadipyl sidechain from l to d. The existence of this epimerase and its extreme lability were later confirmed in Oxford49'50).
It is quite remarkable that within two years of the Konomi's40) paper, a scheme of penicillin and cephalosporin biosynthesis, including the steps of cephamycin synthesis by actinomycetes, could be presented5]) and remains essentially correct today. The further hydroxylation of DAOC to deacetylcephalosporin C was shown to be catalyzed by cell-free extracts containing another aketoglutarate-linked dioxygenase52~54). The conversion of deacetylcephalosporin C to cephalosporin C was found to be carried out by the enzyme acetyl CoA:
deacetylcephalosporin C acetyltransferase52'55).
Once the active cell-free preparations were available, purification of the cyclase, epimerase and expandase proceeded in our Iaboratory46'56) and in others57~59).
However, up until the mid-1980s, the reaction(s) leading to LLD-ACV was still unknown. It appeared the dipeptide LL-AC must be involved because of the early finding by30) that broken cells could incorporate 14C-DL-valine into LLD-ACV but only when LL-AC was added. Gerald Banko in my laboratory spent a full year trying to demonstrate the production of LL-AC from L-aaminoadipate plus L-cysteine by cell-free extracts of C acremonium but without success until he used 50% glycerol during sonication of the cells. With this modification, he was able to carry out a linear synthesis of LL-ACfrom its constituent amino acids for at least 6 hours, the reaction being dependent upon ATP and Mn2+ or Mg2+ 60 and the first exhibited inhibition by its product, LLD-ACV formation via the reaction LL-AC+ L-valine would be faster than LL-AC formation from L-a-aminoadipate + lcysteine. We found this to be the case; however we unexpectedly observed that the conversion of the three amino acids to LLD-ACVwas far more rapid than either of the two half reactions. We thus concluded that our cell-free preparation contained a single enzyme (which we designated ACV synthetase) which required the simultaneous binding of all three amino acids for maximum activity. We were able to support this conclusion by purification of ACVsynthetase from C. acremoniumb2\ A summaryof this work on ACV synthetase has been published63) as well as the use of this enzymeas a model system for enzymatic peptide synthesis64).
Today, much is known about /3-lactam biosynthesis65). It is clear that the sub-cellular enzyme work begun in the Oxford laboratory of Edward P. Abraham provided the breakthrough needed by the field for elucidation of the pathways leading to fungal penicillins and cephalosporins. It also opened the way for our understanding of the production of cephamycins, clavams and other /3-lactams by the actinomycetes and other bacteria. The isolation of the pure enzymes, determination of their crystal structures66), discovery of the genes involved67) and their chromosomal locations, elucidation of the regulation of the genes and enzymes68'69), cloning and expression of the genes in heterologous hosts70) and consideration of the evolutionary relationships7^all followed on the heels of the development of reliable cell-free systems. I will always be indebted to the late Edward P. Abraham for his scholarship, his highly ethical character and his generous offers to help a young industrial microbiologist contribute to the world of technology and science. 
